Last financial report (EOFY) shows they have ~$9M current assets. Running at ~$5M loss a year at moment (>60% of annual expenses are R&D).
They have arrangements with GE which is revenue generating.
Share price was penalized heavily due to recent trials for lung fibrosis.
I cannot advise on why you should invest, but I am sure I saw you pop up here previously (I could be wrong). Anyways back to the day job.
Add to My Watchlist
What is My Watchlist?